Today’s AI Top Pick: CELH

7/24/2026 · Highly Shorted Turnaround Deep Rotation screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Today's pick · Highly Shorted Turnaround Deep RotationCELHBUY NOW8.8 / 107/24/2026

CELH is the cleanest setup in this pool right now — the fundamentals AND the tape both align, with no negative headline landmines. On the screen it carries the highest fundamental_score in the group (8) alongside PGY, but unlike PGY it doesn't have a weekly forecast that goes deeply negative (PGY 1wk fc: -28.86%/-29.16%/-42.04%). CELH shows salesYoY of 123.34%, profitMargin 3.68%, operMargin 19.8%, ROE 13.69%, epsNextY 23.56%, recom 1.36, and targetUpsidePct of 106.1% — a textbook growth-turnaround profile after a -39.84% year and -40.6% YTD wash-out. The multi-timeframe tape is exactly what you want on a bottom-fisher: price is at the low of the range on every TF (pos_in_21bar_range 7.14% on 1h, 2.69% on 4h, 1.67% on 1d, 0% on 1wk) with a -38.82% weekly drawdown already priced in — you are demonstrably NOT chasing. Forecasts are broadly aligned up: 1h +14.06/+7.73/+11.95%, 4h +0.71/+9.28/+49.71%, 1d +39.94/+64.14/+72.31%, 1wk -1.88/+35.46/+39.08%. The only mild wobble is the 1wk short-horizon -1.88% but mid/long weekly is +35–39%, and bullish_prob is 1.0 with near_term_bullish 0.8. The news flow is benign-to-positive (Motley Fool 'best stocks' mention, Zacks noting outperformance) — no dilution, no guidance cut, no regulatory issue, no short-seller report. Compare that to BIRK (Seaport downgrade), MNDY (mass layoffs restructuring — a red flag even if framed as AI-strategic), TMDX (Evercore price-target cut), FLWS (NY AG $375K settlement for deceptive practices), or MBRX (interim trial data missed significance on 6/30). CELH gets a clean pass. Why today, not later? Because we are at the literal bottom of every TF range with forecasts pointing up 35–72% on mid/long daily and weekly horizons. Waiting for confirmation means paying up 10–15% into the 4h/1d forecast cone. Stop placement is well-defined below the 21-bar weekly low, so risk/reward is asymmetric.

Entry zone

$26.80–$27.50 (accumulate at/near current $27.27; scale in on any dip to $26.00)

Stop loss

$24.20 (below the weekly low that produced the -38.82% drawdown; a break there invalidates the turnaround)

First target

$32.00 (~+17%, aligns with 1d fc_short +39.94% envelope midpoint and reclaims prior consolidation)

Longer target

$40–$45 (~+47–65%, aligns with 1d fc_mid +64.14% / fc_long +72.31% and weekly fc_mid/long +35–39%; analyst target upside 106%)

Risks

Consumer Defensive energy-drink category slowdown — perfYear -39.84% reflects genuine demand deceleration, not just multiple compression
fwdPe 13.74 is reasonable but trailing PE 64.86 and debtEq 1.95 leave no room for another guide-down
shortFloat 19.95% can fuel a squeeze but also means smart money is still positioned against — a bad print could see fresh shorting
1wk fc_short is -1.88% — the immediate next week could still see a retest of lows before the mid/long-term move plays out
Sector rotation risk: if capital rotates out of consumer names into AI/defense (as ZENA, PDYN, MP headlines suggest), CELH could underperform even in an up-tape

Honorable mentions

QXONear_term_bullish 1.0 with 4h fc +36.56/+30.67/+46.33% and 1d +5.32/+39.14/+39.15%, sitting at pos_in_range 0% on weekly with -44.2% drawdown. epsNextY 133.19%, salesYoY 15,198% (acquisition-driven), recom 1.13. Fed rate-cut tailwind for household durables cited in Benzinga. Lower fund_score (4.75) than CELH because of negative margins keeps it #2.

TMDXfund_score 6.75, ROE 45.22%, profitMargin 27.04%, epsNextY 70.61%. Near_term_bullish 1.0 with 1h/4h/1d forecasts all strongly positive (1d +31/+72/+61%). Evercore PT cut to $90 is a modest negative but they maintained Outperform — thesis intact.

Full ranking (30)

#	Symbol	Verdict	Score	Read
1	CELH	BUY NOW	8.8	Bottom of range on every TF with 1d fc +40/64/72%, clean news, fund_score 8 — the textbook setup.
2	QXO	BUY NOW	8.0	Full near-term bullish, deep -44% weekly drawdown, 4h fc +30–46% and Fed cut tailwind.
3	TMDX	BUY NOW	7.6	Best profitability in group (ROE 45%, PM 27%), 1d fc +31/+72/+61%, only headwind is modest Evercore PT trim.
4	WING	BUY NOW	7.3	Pos_in_range 0% on 1d, dd -41%, 1d fc +35/+64/+77%, operMargin 28%, fund_score 6.
5	BRZE	BUY NOW	7.1	JPM raised PT to $35, GS positive, 1wk fc +11/+38/+38%, not stretched (pos 23–35%).
6	MNDY	BUY PULLBACK	6.5	1wk fc +84/+184% but the layoff/restructuring headline creates near-term overhang.
7	KVYO	BUY NOW	6.3	1d fc +14/+36/+43%, CFO transition orderly, undervalued software call from Insider Monkey.
8	PSIX	BUY PULLBACK	6.2	Best valuation (PE 7, ROE 76%) and 1d fc +50/+133/+118%, but 1wk fc negative (-4/-26/-32%) demands patience.
9	BIRK	WAIT	5.9	Solid fund_score 7.5 but Seaport downgrade to Neutral and 1wk fc negative undercut the setup.
10	PGY	WAIT	5.7	Fund_score 8 but 1wk fc -29/-29/-42% is a big red flag right at pos 77%.
11	MP	BUY PULLBACK	5.5	Critical-metals tailwind, 1h/4h fc +27–47% but 1wk fc -24/-40% and Needham PT cut.
12	ABAT	BUY PULLBACK	5.3	DOE grant reinstated ($57M), 4h fc +46/+53/+75%, but weekly still in downtrend at pos 0%.
13	ZENA	BUY NOW	5.2	USAF/defense drone catalysts, 1d fc +13/+157/+158%, near_term 1.0, but micro-cap risk.
14	ASPI	BUY PULLBACK	5.0	Helium listing catalyst, 4h fc +53/+43/+47%, but weekly dd -48% and pos 3.67% suggests not done bottoming.
15	PROP	BUY PULLBACK	4.9	4h fc +92/+120/+102%, but debtEq 1222 and profitMargin -46% are extreme.
16	PDYN	BUY PULLBACK	4.8	USAF STRATFI extension positive, 1h/4h fc +25–35%, but weekly fc negative.
17	TTAN	WAIT	4.5	At 100% of 1h range with 1h/4h/short-1d fc negative — chasing risk high.
18	GLXY	BUY PULLBACK	4.4	Crypto beta play, $3.5B debt raise ambiguous, 1d fc mild (+27% long only).
19	ASST	BUY PULLBACK	4.3	TD Cowen maintains Buy but cut PT; 1d fc +20/+19/+94%, but ps 175 is nosebleed.
20	TNXP	WAIT	4.2	Medicare coverage expansion positive, weekly fc absurd (+8593%) suggests outlier not signal.
21	MBRX	AVOID	4.0	6/30 trial data missed significance; -25% drop; weekly fc +951% is noise from tiny base.
22	EYE	WAIT	3.9	Near_term_bullish 0, weekly fc -7 to -9%, at top of 1h/4h range.
23	KULR	WAIT	3.8	Icarus contract positive but 1d fc slightly negative and pos_in_range 0% on 1h/4h means still bleeding.
24	INV	AVOID	3.7	profitMargin -5226%, ps 76, no near-term signal, CEO transition uncertainty.
25	SAIL	WAIT	3.5	Bullish_prob null, insider selling flagged, 1h/short-1d fc negative.
26	CTXR	BUY PULLBACK	3.3	LYMPHIR launch positive but micro-cap ($14M), weekly fc +313% is unreliable spike.
27	RDW	AVOID	3.0	bullish_prob 0.5, mixed narratives (SA bull vs StockStory sell), 4h/1d/1wk fc weakening.
28	DFDV	AVOID	2.8	debtEq 12.54, profitMargin -1136%, Cantor cut PT — thesis broken.
29	UPXI	AVOID	2.5	profitMargin -874%, Cantor cut PT to $1.3, no fresh catalyst.
30	FLWS	AVOID	2.0	NY AG $375K deceptive-practices settlement is a fresh landmine; also flagged as unprofitable.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord